CSL412

· Seqirus

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSL412, covering 2016-07-19 to 2016-07-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants [Phase 2]